1. Intestinal mucosal permeability in inflammatory rheumatic diseases;Mielants, H.; Goemaere, S.; De Vos, M.; Schelstraete, K.; Goethals, K.; Maertens, M.;I. Role of antiinflammatory drugs. J Rheumatol,1991
2. Intestinal mucosal permeability in inflammatory rheumatic diseases;Mielants, H.; De Vos, M.; Goemaere, S.; Schelstraete, K.; Cuvelier, C.; Goethals, K.;II. Role of disease. J Rheumatol,1991
3. Ileocolonoscopic findings in seronegative spondylarthropathies;Mielants, H.; Veys, E.M.; Cuvelier, C.; De Vos, M.;BrJ Rheumatol,1988
4. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study;Mielants, H.; Veys, E.M.; Goemaere, S.; Goethals, K.; Cuvelier, C.; De Vos, M.;J Rheumatol,1991
5. Intestinal mucosal permeability in inflammatory rheumatic diseases;Mielants, H.; Goemaere, S.; De Vos, M.; Schelstraete, K.; Goethals, K.; Maertens, M.;I. Role of antiinflanimatory drugs. J Rheumatol,1991